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Abstract
Background: Parkinson’s disease is a chronic, neurodegenerative disease characterized by gait abnormalities. Freezing
of gait (FOG), an episodic inability to generate effective stepping, is reported as one of the most disabling and
distressing parkinsonian symptoms. While there are no specific therapies to treat FOG, some external physical cues may
alleviate these types of motor disruptions. The purpose of this study was to examine the potential effect of continuous
physical cueing using robot-assisted sensorimotor gait training on reducing FOG episodes and improving gait.
Methods: Four individuals with Parkinson’s disease and FOG symptoms received ten 30-minute sessions of robot-
assisted gait training (Lokomat) to facilitate repetitive, rhythmic, and alternating bilateral lower extremity
movements. Outcomes included the FOG-Questionnaire, a clinician-rated video FOG score, spatiotemporal
measures of gait, and the Parkinson’s Disease Questionnaire-39 quality of life measure.
Results: All participants showed a reduction in FOG both by self-report and clinician-rated scoring upon completion
of training. Improvements were also observed in gait velocity, stride length, rhythmicity, and coordination.
Conclusions: This pilot study suggests that robot-assisted gait training may be a feasible and effective method of
reducing FOG and improving gait. Videotaped scoring of FOG has the potential advantage of providing additional
data to complement FOG self-report.
Background
Freezing of gait (FOG) is a common yet poorly under-
stood gait phenomenon in persons with Parkinson’s dis-
ease (PD). Defined as an episodic inability to generate
effective stepping [1], FOG is reported to be one of the
most disabling, the second most distressing, and the
third most intense parkinsonian symptom [2,3]. Patients
often describe FOG as a feeling that their feet are “stuck
to the floor” despite attempts to force themselves to
walk. Cross-sectional studies indicate increasing preva-
lence of FOG with duration of disease. Approximately
30% of PD patients experience FOG within 5 years, and
nearly 60% after 10 years [4-6]. Predisposing factors that
may contribute to FOG include abnormalities of gait
such as arrhythmicity and asymmetry [7].
Available pharmacological agents have a limited effect
on FOG or other gait symptoms; however, intermittent
somatosensory cues, such as simple visual and tactile
cues, may alleviate freezing by acting as positive media-
tors of gait. Nieuwboer and colleagues investigated the
potential therapeutic role of external physical cues for
individuals with PD who experience FOG (PD+FOG) to
improve gait-related mobility in the RESCUE trial [8].
However, simple external cues may not be sufficient to
reduce FOG. For example, adding treadmill training to
visual and auditory cues was more beneficial than cueing
alone in individuals with PD+FOG [9]. The Lokomat
(Hocoma, Zurich, Switzerland) is an external device
explicitly designed to physically guide repetitive, rhyth-
mic, bilateral lower extremity movements in order to
g e n e r a t eam o r en o r m a lg a i tc y c l e .T h i st y p eo fi n t e n s e
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reinforce gait automaticity, thus reducing FOG. The
objective of this pilot study was to examine the extent to
which FOG and gait arrhythmicity would be ameliorated
by using robot-assisted gait training in a small case series.
We hypothesized that robot-assisted gait training would
reduce FOG frequency and severity, and improve gait. To
our knowledge, robot-assisted gait training has not pre-
viously been evaluated as a therapy to specifically treat
FOG.
Methods
Participants
Five individuals with idiopathic PD and primarily “OFF”
freezing were recruited from a local Movement Disor-
ders Clinic. Participants were screened at a baseline
visit, which included a physical and neurological exam
as well as the Unified Parkinson’s Disease Rating Scale
(UPDRS) assessment. Inclusion criteria were: (1) diagno-
sis of idiopathic PD by UK Brain Bank criteria, without
other significant neurological problems; (2) between the
ages of 18-85 years; (3) history of FOG during the “ON”
phase of medication by self-report and verified by a neu-
rologist (at screening and baseline); and (4) able to walk
25 feet unassisted.
Exclusion criteria were: (1) unable to understand
instructions required by the study (Informed Consent
Test of Comprehension); (2) primarily wheelchair
bound; (3) presence of medical or neurological infirmity
that might contribute to significant gait dysfunction; (4)
uncontrolled hypertension > 190/110 mmHg; (5) history
of uncontrolled diabetes; (6) significant symptoms of
orthostasis when standing up; (7) circulatory problems,
history of vascular claudication or pitting edema; (8)
body weight over 100 kg; (9) lower extremity injuries or
joint problems (hip or leg) that limit range of motion or
function, or cause pain with movement; (10) pressure
sores with any skin breakdown in areas in contact with
the body harness or Lokomat apparatus; (11) chronic
and ongoing alcohol or drug abuse, active depression,
anxiety or psychosis that might interfere with use of the
equipment or testing; (12) inability to participate in and
complete the training sessions; (13) diagnosis of atypical
parkinsonian syndrome; or (14) implantation of deep
brain stimulation.
The Providence Veterans Affairs Medical Center
(PVAMC) Institutional Review Board approved the pro-
tocol, and informed consent was obtained for all partici-
pants. The study was registered on ClinicalTrials.gov
(Identifier #NCT00819949).
Intervention
The Lokomat is a commercially available system that
offers mechanical guidance of lower extremity trajectories
(Figure 1). The hip and knee components of the exoskele-
ton are driven by linear back-drivable actuators that repe-
titively facilitate bilateral symmetrical gait patterns [10,11].
The Lokomat unit is secured to the lower extremity and
pelvis using adjustable pads, cuffs and Velcro straps. The
system uses a dynamic body weight-support system
to support the participant above a motorized treadmill
synchronized with the Lokomat.
Participants received 10 sessions of robot-assisted body
weight-supported treadmill training (BWSTT) on the
Lokomat. Training occurred approximately twice a week
for five weeks, and each training session on the Lokomat
lasted 30 minutes. All sessions were supervised by a
trained research therapist. All participants started with
40% body weight-support and an initial treadmill speed
of 1.5 km/h. Body weight-support was used primarily to
facilitate an increase in walking velocity; therefore, pro-
gression of training across subsequent sessions was stan-
dardized by preferentially increasing speed and then
unloading body weight-support. Speed was increased to a
range of 2.2 to 2.5 km/h before body weight-support was
decreased. There was an active attempt to progress the
training at each session. By the tenth training session, all
participants were walking without body weight-support.
Outcome Assessments
All outcome assessments were conducted approximately
1 hour after participants took their usual medication to
ensure they were in an “ON” phase. Participants were
instructed to come to the research facility at the same
time and on the same days each week to ensure testing
consistency. All outcome assessments were collected at
baseline (approximately one week before the first train-
ing session) and endpoint (approximately one week after
the last training session), and included:
- The Freezing of Gait-Questionnaire (FOG-Q): This
self-reported assessment has been shown to reliably
detect the impact of FOG and assess the effective-
ness of treatment [12,13]. Questions 1-2 pertain to
general gait difficulties, while question 3 refers to
FOG frequency and questions 4-6 refer to FOG
severity. The questionnaire was administered at
baseline, before each training session, and at end-
point. In order to reduce recall bias, the baseline
FOG-Q score reflects the second time the question-
naire was presented (i.e., prior to Lokomat training
at Session 1).
- FOG and Falls Diary: Participants were asked to
record the date and number of any FOG episode or
fall that occurred throughout the training period.
Participants were given the calendar at baseline and
it was collected and reviewed at each training ses-
sion. A fall was defined as an event resulting in a
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or a level lower than waist height, and not as a con-
sequence of a violent blow, sudden loss of con-
sciousness, or paralysis [14].
- Posture and Gait Score: This score includes ques-
tions 13-15 and 29-30 of the UPDRS, and has been
used as an outcome measure to assess gait and bal-
ance in individuals with PD [9,15].
- Gait Parameters: Spatiotemporal gait characteristics
were recorded using a 29-foot instrumented walkway
(GAITRite Mat, CIR Systems) calibrated for 25 feet
of data collection, placed in a hallway with minimal
distractions. Participants completed two walking
trials at a comfortable pace down the walkway.
- Gait Rhythmicity, Asymmetry, and Coordination
(CV, GA, PCI): These measurements are used to
describe bilateral gait coordination, rhythmicity and
asymmetry. Coefficient of variation (CV) of spatiotem-
poral gait parameters is used to describe gait variabil-
ity, with higher values indicating a more variable gait.
Gait asymmetry (GA) is the natural log of the ratio of
the swing time of each lower limb, where higher values
indicate more asymmetrical gait patterns. Phase coor-
dination index (PCI) assesses the relationship between
step time and stride time as well as the variability of
that relationship; higher values indicate decreased
coordination of the lower extremities [7].
- Parkinson’s Disease Questionnaire-39 (PDQ-39):
This questionnaire examines 8 dimensions of quality
of life specific to PD patients and is scored on a 5-
point scale. As a disease-specific questionnaire, the
PDQ-39 is highly reliable and valid [16].
- Visual FOG (vFOG): Using a clinican-based scoring
method adapated from Schaafsma and colleagues
[17], we assessed the frequency and severity of an
individual’s FOG episodes. A high definition camcor-
der mounted on a stationary tripod was used. It
faced the participant at one end of the 10-meter
FOG testing pathway, approximately 5 feet away
from where the turns occurred. All participants
completed a series of five videotaped walking trials
and were asked to stand from a seated position,
walk 10 meters, turn, and walk back. Participants
completed all five trials continuously, but were
allowed to rest between trials if fatigued. The walk-
ing trials were completed at baseline, twice each
training session (once prior to and once immediately
after), and endpoint. The videotapes were coded and
scored by a trained neurologist blinded to time point
of assessment. The rater was allowed to stop and
replay the video during scoring. In order to eliminate
a potential novelty or training effect, the trials con-
ducted prior to training at session 1 were used as
baseline measurements for data analysis.
Data Analysis
Self-reported freezing and falls data were each averaged
to obtain the number of freezes per day, as well as the
number of falls per week throughout the course of the
training period. The gait parameters were calculated by
GAITRite software (v3.9), and included overall velocity
and cadence, as well as limb-specific step length, stride
length, and percentage of time spent in swing and double
Figure 1 (A). The Lokomat, an automated gait orthosis on a treadmill with a body weight-support system; (B). Lokomat leg orthosis.
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aged to obtain a single value; the values of the two trials
were then averaged. The CV (standard deviation/mean ×
100) was calculated for step length, stride length, stride
time and swing time for each participant. GA was calcu-
lated as: GA = 100 × |ln (SSWT/LSWT)|, where SSWT
and LSWT represent short mean swing time and long
mean swing time, respectively [18]. PCI was calculated
according to Plotnik and colleagues [18].
The PDQ-39 subsection and standard index (SI) score
effect sizes (mean difference/standard deviation at base-
line) were calculated according to instructions provided
in the PDQ-39 handbook, and compared to reported
values of significant meaningful change [19].
In order to generate the vFOG scores, videotapes of the
5 walking trials for each participant at each session were
randomized and scored by a trained neurologist, blinded
to time point. Frequency of FOG was scored by calculat-
ing the mean number of FOG episodes that occurred
during the five walking trials under the contexts of: 1)
initiation from standstill, 2) open runway walking, 3)
onset of turn, 4) turning 180°, and 5) initiation after turn-
ing. A “freeze” was defined as an event when the foot
appeared to be “stuck,” and a visible attempt was made
to move, but the foot was unable to proceed as during
start hesitations or transient blocks in the middle of
motions [17,20]. Severity of FOG was measured by the
duration (in seconds) of each freeze that occurred in
each of the five contexts previously described. The sever-
ity of FOG score was obtained by calculating the mean
number of seconds that each FOG episode lasted within
each context over the 5 trials, for each videotaped ses-
sion. Data is reflected as median and interquartile range
[25
th percentile, 75
th percentile] unless otherwise stated.
Results
Four participants completed all 10 sessions; one partici-
pant withdrew after four training sessions due to trans-
portation issues. There were no serious adverse events
related to the study. The median age was 62.0 [53.8,
71.5] years, and disease duration was 5.2 [2.7, 8.8] years.
The median UPDRS III score was 20.5 [16.8, 24.5]. Par-
ticipant demographics are presented in Table 1.
Motor and Quality of Life Outcomes
All participants displayed a reduction of FOG by self-
report in response to the intervention. Participants
showed a 20.7% reduction in average frequency of
freezes per day as recorded on the FOG calendars, with
three participants reporting 2-3 fewer episodes of freez-
ing per day. One participant did not report any change
in freezes per day, but did report 4 fewer falls per week.
T h e r ew a sa1 3 . 8 %i m p r o v e m e n to nt h eF O G - Qf r o m
baseline to end of training (Table 2); specifically, severity
of freezing improved 41.7% in “overall” and “initiation”
FOG, which correspond to questions 4 and 5 of the
FOG-Q.
Gait velocity and stride length improved 24.1% and
23.8%, respectively (Table 2). Participants also demon-
strated a reduction in step length CV, swing time CV,
a n ds t r i d et i m eC V ,a sw e l la sP C I( T a b l e3 ) .S t r i d e
length CV was reduced for three of the four partici-
pants. Only one participant demonstrated a decrease
in GA.
There were meaningful effect size changes among par-
ticipants in quality of life subsections as per the PDQ-39
handbook (Table 4) [19]. These subsections included
mobility, ADLs, emotional well-being, stigma, social
support, cognitions, bodily discomfort, and the overall
standard index score. Only one sub-dimension, commu-
nication, did not show meaningful change from baseline
to end of training.
Clinician-Rated vFOG Outcome
Median frequency vFOG scores improved 73.2% imme-
diately following training sessions (Figure 2). Addition-
ally, median frequency vFOG scores improved 62.5%
from baseline to end of training. The severity of FOG
was reduced in all walking contexts for all participants
from baseline to end of training (Figure 3).
Discussion
To our knowledge, this is the first study to examine the
effects of robot-assisted BWSTT on FOG in individuals
with PD+FOG. Our results showed that ten 30-minute
sessions of robot-assisted treadmill training may reduce
FOG frequency and severity, as well as abnormal gait
Table 1 Demographics
Participant 1 Participant 2 Participant 3 Participant 4
Age (years) 67 57 85 44
Sex M M M F
Race White White White White
Height (cm) 170.2 177.8 173.0 175.3
Weight (kg) 59.5 100.0 72.6 66.0
Disease duration (years) 14.0 3.5 0.2 7.0
UPDRS III (ON) 22 10 19 32
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more, we saw evidence for improved balance and
decreased frequency of falls. The intervention also resulted
in meaningful changes in seven of the eight quality of life
dimensions, as well as in the overall PDQ-39 score. The
vFOG scoring method demonstrated the possibility of
evaluating FOG frequency and severity to assess changes
after an intervention using videotaped sessions of five
10-meter walks including turns.
A previous study reported the directionally restricted
e f f e c t so fg a i tt r a i n i n go nr e d u c i n gF O G .H o n ge ta l .
(2008) used a rotating treadmill to improve FOG symp-
toms in two participants, but found that FOG decreased
only in the trained direction [21]. In contrast, our study
involved only continuous straight walking and no speci-
fic training for turns. We found decreased frequency of
FOG during turn onset and after turning, as well as
decreased severity of FOG for all aspects of turning
(onset, during and after turning).
FOG-Q scores improved for severity of FOG epi-
sodes (questions 4-6), but not for frequency of FOG
(question 3). The FOG-Q only has one question
regarding FOG frequency compared to three questions
on severity. Therefore, the FOG-Q may not be as sen-
sitive to measure frequency of FOG. Total FOG-Q
scores showed moderate improvement over the five
week training protocol (2 points); this is less than what
was reported by Frazzitta and colleagues (5.1 points),
who also used a treadmill intervention to treat FOG
[9]. The differences between the current study and
Frazzitta et al. might be attributed to variations in
both frequency and type of treadmill training para-
digm. Frazzitta et al. incorporated a high intensity
training protocol (20 min/day, every day for 4 weeks)
into a multi-dimensional treadmill training paradigm
augmented with auditory and visual cueing. In terms
of gait changes, our results showed comparable
improvements in gait velocity, despite the fewer num-
ber of sessions in our study (10 vs. 28 sessions).
Furthermore, our study demonstrated a larger magni-
tude of change in gait velocity despite slower baseline
Table 2 Changes in Motor Outcomes Following Robot-Assisted Gait Training
Participant 1 Participant 2 Participant 3 Participant 4 Median % Change
Baseline Endpoint Baseline Endpoint Baseline Endpoint Baseline Endpoint
Freezing of Gait
FOG-Q (total) 15.0 13.0 14.0 13.0 15.0 12.0 14.0 12.0 -13.8%
Question 3 3.0 3.0 3.0 3.0 4.0 4.0 3.0 3.0 0%
Questions 4-6 8.0 5.0 6.0 6.0 7.0 4.0 6.0 3.0 -35.4
Average Freezes/Day 8.6 6.4 4.6 1.8 17.4 14.6 3.8 3.8 -20.7%
Balance
Posture & Gait Score 8.0 5.5 6.0 6.0 5.0 5.0 12.0 10.0 -8.3%
Falls
Avg. Falls/Week 0.0 0.0 4.0 2.0 0.0 0.0 12.0 8.0 -16.7%
Gait
Velocity (cm/sec) 106.8 111.3 55.8 72.2 91.6 109.0 58.8 87.7 24.1%
Cadence (steps/min) 114.0 111.4 89.2 88.2 113.9 114.7 112.8 98.4 -1.7%
Stride Length (cm) 112.9 120.2 75.4 97.9 96.5 113.5 62.3 107.5 23.8%
Double Support (%) 26.6 26.4 38.4 32.0 29.6 25.5 41.6 25.4 -15.2%
Swing (%) 36.8 36.9 30.8 34.0 35.0 37.2 29.1 37.2 8.6%
Step Length (cm) 56.2 60.0 37.5 49.1 60.0 57.0 29.8 53.4 18.8%
Table 3 Gait Rhythmicity, Symmetry and Coordination
Baseline Endpoint
Swing Time CV (%) 10.2 [9.0, 12.6] 6.7 [6.1, 7.4]
Stride Time CV (%) 4.1 [4.0, 5.2] 3.6 [3.2, 4.0]
Stride Length CV (%) 6.5 [5.8, 10.3] 4.4 [3.6, 5.2]
Step Length CV (%) 8.0 [6.1, 14.2] 5.7 [5.3, 6.7]
Gait Asymmetry (GA) 1.9 [0.5, 4.9] 3.9 [2.9, 4.5]
Phase Coordination Index (PCI) (%) 9.0 [7.3, 12.3] 7.8 [6.6, 8.1]
Table 4 Mean (n = 4) Effect Sizes in Quality of Life
Domains Following Robot-Assisted Gait Training
Effect Size
PDQ-39 SI* -0.46
Mobility* -0.20
ADLs* -0.34
Emotional well-being* -0.56
Stigma* -0.49
Social Support* -0.52
Cognitions* -0.59
Communication -0.06
Bodily Discomfort* -0.21
*Denotes meaningful change in the PDQ-39 subsection score.
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ing cueing in individuals with PD+FOG [8].
O u rr e s u l t ss u p p o r tt h ec o n c e p tt h a ti n d i v i d u a l sw i t h
PD+FOG exhibit abnormal gait patterns even in the
absence of freezing episodes, which has been suggested
previously [7]. Decreased stride length and increased
step length variability have been attributed to increased
FOG episodes [22-24]. We observed considerable
improvements in stride length and step length CV after
training, trending toward previously reported step length
CV values for individuals with PD without FOG [22].
Furthermore, the results show improvement in overall
gait coordination after treatment, as measured by PCI.
PCI has been used to describe gait coordination in indi-
viduals with PD and PD+FOG [7,18,25]; however,
change in PCI has not been examined as an outcome
variable following intervention for individuals with PD
+FOG. The participants in this study demonstrated
improvements in overall PCI (9.0 to 7.8), approaching
values previously reported for individuals with PD who
do not experience FOG (6.95) [25]. While improvements
were observed in all other measures pertaining to gait,
this was not true for gait asymmetry (GA). This dichoto-
mous change of improved coordination along with
greater asymmetry may suggest that although gait pat-
terns appear more asymmetrical, they are also more
coordinated, consistent and rhythmic [18]. Similar
changes in gait coordination versus GA are seen follow-
ing levodopa treatment and results in a differential effect
on improving PCI, but with no changes observed in
GA [7].
Quality of life measures in the present study showed
improvements in several domains investigated. Tread-
mill training has been shown to have beneficial effects
on quality of life in individuals with PD only [26,27],
while studies incorporating other methods of rehabilita-
tion in individuals with PD+FOG have shown no
changes in quality of life [8]. Results from the current
s t u d ys h o w e di m p r o v e m e n ti nq u a l i t yo fl i f ed o m a i n s
that might have been expected to benefit from treadmill
training such as mobility and ADLs; however, additional
beneficial effects were found on unexpected domains
such as emotional well-being, cognition, and stigma.
This study was limited by the small number of partici-
pants and lack of a control group; there is the possibility
that the changes observed may be due to a placebo effect
or fluctuating responses to medication. Additionally, pre-
vious literature has suggested that treadmill training may
be more beneficial than conventional physical therapy for
improving gait in individuals with PD [28].
A potential limitation of prior FOG studies has been
the reliance on using the self-reported FOG-Q. To
address this limitation, our study included multiple
methods to verify FOG. Our clinician-rated vFOG score
demonstrated a reduction of FOG frequency and severity;
however, there are several issues that should be
addressed. Our initial intent was to develop a relatively
simple walking task incorporating events similar to those
i nt h eF O G - Qa n dap r e v i o u ss t u d yt h a ta s s e s s e dF O G
through structured video assessment [17]; however, our
10-meter walking task did not provoke a high volume of
freezing. Without a sufficient number of freezing epi-
sodes, it is difficult to document large changes due to
treatment. The challenge of eliciting FOG episodes
within the clinic, despite reports of FOG occurring at
home, has been previously reported [5,29].
Conclusions
These study results show that robot-assisted gait train-
ing is a promising therapy to reduce FOG events and
improve gait parameters in participants with PD+FOG.
The current study extends the knowledge of potential
clinical therapeutic strategies and FOG outcomes used
to treat and monitor gait abnormalities present in indi-
viduals with PD+FOG. Future studies should include
Figure 2 Frequency vFOG scores (median of all scores,
recorded before and after each training session).
Figure 3 Severity vFOG scores for all contexts (n = 4).
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of FOG, as well as situations that elicit freezing, such as
walking through narrow spaces and turning, since very
few freezing events occur along straight pathways, as
observed by this study and by Schaafsma et al. 2008
[17]. Furthermore, follow-up evaluations should be con-
ducted to assess whether there are any long-term
improvements from robot-assisted gait training.
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